SCHEMBL30385303

SCHEMBL30385303

COc1ccc(-c2cnc3c(Nc4ccc(C(=O)O)c(Cl)c4)nccn23)c(F)c1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTK6 Q13882 10/20 0.48
▸ EGFR P00533 1/20 0.41
▸ SYK P43405 2/20 0.38
▸ AURKB Q96GD4 3/20 0.38
▸ AURKA O14965 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ CCNB2 O95067 1/20 0.38
▸ CCNE2 O96020 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ NTRK1 P04629 1/20 0.38
▸ INSR P06213 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ CCNB1 P14635 1/20 0.38
▸ PRKACA P17612 1/20 0.38
▸ CCNA2 P20248 1/20 0.38
▸ PRKACG P22612 1/20 0.38
▸ PRKACB P22694 1/20 0.38
▸ CCNE1 P24864 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ MAPK3 P27361 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22123969 1.00 PTK6 (0.48) PTK6EGFRSYKAURKBAURKA
SCHEMBL30385212 0.93 PTK6 (0.50) PTK6SYKAURKBMAPKAPK5LCK
SCHEMBL22139113 0.92 PTK6 (0.48) PTK6SYKAURKBAURKAINSR
SCHEMBL30172107 0.92 PTK6 (0.48) PTK6SYKAURKBAURKAINSR
SCHEMBL25170422 0.91 SYK (0.41) PTK6SYKAURKBMAPKAPK5DHODH
Trifluoroacetic Acid SCHEMBL30386106 0.90 PTK6 (0.47) PTK6EGFRSYKAURKBMAPKAPK5
SCHEMBL22125440 0.90 PTK6 (0.59) PTK6AURKBLCK
SCHEMBL30171569 0.90 PTK6 (0.59) PTK6AURKBLCK
SCHEMBL25167694 0.90 PTK6 (0.47) PTK6AURKBKDM4ECCNB2CCNE2
SCHEMBL25170375 0.90 PTK6 (0.40) PTK6SYKAURKBAURKAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161931-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2023-04-12 — — EP disclosed
Send feedback